Louise Bergeron provides strategic and scientific advice to advance novel oncology therapeutic agents to the clinic. She specializes in early phase drug discovery with a focus on selecting therapeutic targets, defining a clear therapeutic strategy, demonstrating mechanism of action, conducting efficacy studies, and developing sound clinical translation plans. In addition, Louise Bergeron provides independent reviews.